Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
CONCLUSIONS: VIT is safe in cutaneous mastocytosis patients with WA, while caution has to be made in case of systemic mastocytosis. VIT was effective in the patients who were re-stung.
PMID: 26549336 [PubMed - in process]
Source: European Annals of Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Health | Immunotherapy | Insect Bites & Stings | International Medicine & Public Health | WHO